Abstract
Peripheral T cell lymphomas are a heterogeneous group of post-thymic, mature lymphoid malignancies, accounting for approximately 10–15% of all non-Hodgkin's lymphomas. A rare entity within this group is represented by hepatosplenic γδ T cell lymphoma, which is characterized by primary extranodal disease with typical sinusoidal or sinusal infiltration of the liver and the spleen, respectively, by expression of the T cell receptor γδ chain, and by a number of other frequent clinicopathological features including aggressive course of disease. In contrast to these common attributes some biologic characteristics such as expression of cytotoxic proteins and cytotoxic activity have been controversial. In this review, clinicopathological, immunophenotypical, molecular biological, cytogenetical and biological findings, and diagnostic and therapeutic difficulties in hepatosplenic γδ T cell lymphoma are discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Farcet J-P, Gaulard P, Marolleau J-P, Le Couedic J-P, Henni T, Gourdin M-F, Divine M, Haioun C, Zafrani S, Goossens M, Hercend T, Reyes F . Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor γδ Blood 1990 75: 2213–2219
Gaulard P, Zafrani ES, Mavier P, Rocha FD, Farcet J-P, Devine M, Haioun C, Pinaudeau Y . Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases Hepatology 1986 6: 864–868
Gaulard P, Bourquelot P, Kanavaros P, Haioun C, Le Couedic JP, Divine M, Goossens M, Zafrani ES, Farcet JP, Reyes F . Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of γ/δ T-cell lymphomas Am J Pathol 1990 137: 617–628
Falcao RP, Voltarelli JC, Simoes BP, Pestana DNR, Zago MA, Figueiredo MS . Malignant T γ/δ lymphoproliferative disease with natural killer lytic activity Am J Hematol 1992 41: 128–131
Ohno T, Komada F, Yamaguchi M, Oka K, Nishii K, Tsuda M, Katsuta K, Yamaguchi T, Kita K, Shirakawa S . Gamma/delta T-cell lymphoma with hepatosplenomegaly: report of a case Int J Hematol 1993 57: 269–276
Mastovic S, Ratech H, Ware RE, Moore JO, Borowitz MJ . Hepatosplenic T-cell lymphoma: an unusual case of γδ T-cell lymphoma with a blast-like terminal transformation Hum Pathol 1994 25: 102–108
Ross CW, Schnitzer B, Sheldon S, Braun DK, Hanson CA . Gamma/delta T-cell post-transplantation lymphoproliferative disorder primarily in the spleen Am J Clin Pathol 1994 102: 310–315
Dommann-Scherrer CC, Kurer SB, Zimmermann DR, Odermatt BF, Dours-Zimmermann MT, Briner J, Heitz PU . Occult hepatosplenic T-γδ lymphoma. Value of genotypic analysis in the differential diagnosis Virchows Arch 1995 426: 629–634
Wang CC, Tien HF, Lin MT, Su IJ, Wang CH, Shuang SM, Shen MC, Liu CH . Consistent presence of isochromosome 7q in hepatosplenic T γ/δ lymphoma: a new cytogenetic-clinicopathologic entity Genes Chromos Cancer 1995 12: 161–164
Wong KF, Chan JK, Matutes E, McCarthy K, Ng CS, Chan CH, Ma SK . Hepatosplenic γδ T-cell lymphoma. A distinctive aggressive lymphoma type Am J Surg Pathol 1995 19: 718–726
Garcia-Sanchez F, Menarguez J, Cristobal E, Cantalejo A, Gil J, Algara P, Vicario JL . Hepatosplenic gamma-delta T-cell malignant lymphoma: report of the first case in childhood, including molecular minimal residual disease follow-up Br J Haematol 1995 90: 943–946
Garcia-Sanchez F, Menarguez J, Algara P . Hepatosplenic γδ T-cell lymphoma Am J Surg Pathol 1996 20: 641 (letter)
Jonveaux P, Daniel MT, Martel V, Maarek O, Berger R . Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T γ/δ lymphoma Leukemia 1996 10: 1453–1455
Yao M, Tien HF, Lin MT, Su IJ, Wang CT, Chen YC, Shen MC, Wang CH . Clinical and hematological characteristics of hepatosplenic T γ/δ lymphoma with isochromosome for long arm of chromosome 7 Leuk Lymphoma 1996 22: 495–500
Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES . Hepatosplenic T-cell lymphoma: a distinct clinicopathological entity of cytotoxic γδ T-cell origin Blood 1996 88: 4265–4274
Alonsozana ELC, Stamberg J, Kumar D, Jaffe ES, Medeiros LJ, Frantz C, Schiffer CA, O'Connell BA, Kerman S, Stass SA, Abruzzo LV . Isochromosome 7q, the primary cytogenetic abnormality in hepatosplenic γδ T-cell lymphoma Leukemia 1997 11: 1367–1372
Sallah S, Smith SV, Lony LC, Woodard P, Schmitz JL, Folds JD . Gamma/delta T cell hepatosplenic lymphoma: review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia Ann Hematol 1997 74: 139–142
Salhany KE, Feldman M, Kahn MJ, Peritt D, Schretzenmair RD, Wilson DM, DiPaola RS, Glick AD, Kant JA, Nowell PC, Kamoun M . Hepatosplenic γδ T cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation Hum Pathol 1997 28: 674–685
Salhany KE, Feldman M, Peritt D, Nowell PC . Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in γδ hepatosplenic T cell lymphoma and post-transplant lymphoproliferative disorders Blood 1997 89: 3490–3491 (letter)
Francois A, Lesesve JF, Stamatoullas A, Comoz F, Lenormand B, Etienne I, Mendel I, Hemet J, Bastard C, Tilly H . Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q Am J Surg Pathol 1997 21: 781–790
Pouderoux P, Gris J-C, Pignodel C, Joujoux J-M, Schved J-P, Balmes J-L . Primary sinusoidal lymphoma of the liver revealed by autoimmune hemolytic anemia Gastroenterol Clin Biol 1997 21: 514–518
Kraus MD, Crawford DF, Kaleem Z, Shenoy S, MacArthur CA, Longtine JA . T γ/δ hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report Cancer 1998 82: 983–992
Ruiz P, Mailhot S, Delgado P, Amador A, Viciana AL, Ferrer L, Zacharievich N . CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma Cytometry 1998 34: 30–35
Ozaki S, Ogasahara K, Kosaka M, Inoshita T, Wakatsuki S, Uehara H, Matsumoto T . Hepatosplenic γδ T-cell lymphoma associated with hepatitis B virus infection J Med Invest 1998 44: 215–217
Weirich G, Sandherr M, Fellbaum C, Richter T, Schmidt L, Kinjerski T, Dietzfelbinger H, Rastetter J, Hofler H . Molecular evidence of bone marrow involvement in advanced case of T γδ lymphoma with secondary myelofibrosis Hum Pathol 1998 29: 761–765
Nosari A, Oreste PL, Biondi A, Costantini MC, Santoleri L, Intropido L, Muti G, Pungolino E, Gargantini L, Morra E . Hepatosplenic γδ T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome Am J Hematol 1999 60: 61–65
Dincol G, Nalcaci M, Yavuz AS, Keskin H, Aktan M, Dogan O, Agan M, Ozbek U, Dincol K . Case of hepatosplenic γδ T-cell lymphoma presenting with severe hypersplenism Am J Hematol 1999 60: 313–314 (letter)
Yamaguchi M, Ohno T, Nakamine H, Oka K, Matsuzuka F, Miwa H, Shiku H, Kimura N, Nanba K, Kita K . γδ T-cell lymphoma: a clinicopathologic study of six cases including extrahepatosplenic type Int J Hematol 1999 69: 186–195
Lin W-C, Moore JO, Mann KP, Traweek T, Smith C . Post-transplant CD8+ γδ T-cell lymphoma associated with human herpes virus-6 infection Leuk Lymphoma 1999 33: 377–384
Kadin ME, Kamoun M, Lamberg J . Erythrophagocytic T γ lymphoma. A clinicopathologic entity resembling malignant histiocytosis New Engl J Med 1981 304: 648–653
Kruskall MS, Weitzmann SA, Stossel TP, Harris N, Robinson SH . Lymphoma with autoimmune neutropenia and hepatic sinusoidal infiltration: a syndrome Ann Intern Med 1982 97: 202–205
Jaffe ES, Costa J, Fauci AS, Cossman J, Tsokos M . Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis Am J Med 1983 75: 741–749
Sun T, Brody J, Susin M, Lichtman S, Boss E, Moskowitz L . Extranodal T-cell lymphoma mimicking malignant histiocytosis Am J Hematol 1990 35: 269–274
Warzynski MJ, Rosen MH, Golightly MG, Steingard RH, Otto RN, Rezuke WN, Johnson ML . An acute form of T γ lymphoproliferative disease presenting with massive splenomegaly – importance of immunophenotyping for diagnosis Clin Immunol Immunopathol 1993 67: 100–108
Lei KI-K, Chow JH-S, Johnson PJ . Aggressive primary hepatic lymphoma in Chinese patients. Presentation, pathologic features and outcome Cancer 1995 76: 1336–1343
Macon WR, Williams ME, Greer JP, Hammer RD, Glick AD, Collins RD, Cousar JB . Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes Blood 1996 87: 1474–1483
Boulland ML, Kanavaros P, Wechsler J, Casiraghi O, Gaulard P . Cytotoxic protein expression in natural killer cell lymphomas and in αβ and γδ peripheral T-cell lymphomas J Pathol 1997 183: 432–439
Lopez-Guillerm A, Cid J, Salar A, Lopez A, Montalban C, Castrillo JM, Gonzalez M, Ribera JM, Brunet S, Garcia-Cone J, Fernandez de Sevilla A, Bosch F, Monserat E . Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the REAL classification Ann Oncol 1998 9: 849–855
Gaulard P, Kanavaros P, Farcet JP, Rocha FD, Haioun C, Divine M, Reyes F, Zafrani ES . Bone marrow histologic and immunohistochemical findings in peripheral T-cell lymphoma: a study of 38 cases Hum Pathol 1991 22: 331–338
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, Wolf-Peters CD, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DJ, Müller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA . A revised European–American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group Blood 1994 84: 1361–1392
Chang KL, Arber DA . Hepatosplenic γδ T-cell lymphoma – not just alphabet soup Adv Anat Pathol 1998 5: 21–29
Bucy R, Chen C, Cooper M . Tissue localization and CD8 accessory molecule expression of Tγδ cells in humans J Immunol 1989 142: 3045–3049
Su IJ, Wang CH, Cheng AL, Chen RL . Hematophagocytic lymphohistiocytosis in Epstein–Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management Leuk Lymphoma 1995 19: 401–406
Rabinowich H, Pricop L, Herberman RB, Whiteside TL . Expression and function of CD7 molecule on human natural killer cells J Immunol 1994 152: 517–526
Carrel S, Salvi S, Rafti F, Favrot M, Rapin C, Sekaly RP . Direct involvement of CD7 (gp40) in activation of TCR γδ T+ T cells Eur J Immunol 1991 21: 1195–1200
Lowin B, Peitsch MC, Tschopp J . Perforin and granzymes: crucial effector molecules in cytotoxic T lymphocyte and natural killer cell-mediated cytotoxicity Curr Top Microbiol Immunol 1995 198: 1–24
Mertens F, Johansson B, Mitelman F . Isochromosomes in neoplasia Genes Chromos Cancer 1994 10: 221–230
Weidmann E, Trucco M, Whiteside TL . Relevance of the T cell receptor for immunotherapy of cancer Cancer Immunol Immunother 1994 39: 1–14
Falini B, Flenghi L, Fagioli M, Martelli MF, Pileri S, Grignani F, Beltrami A, Novero D, Pelicci P-G . T-lymphoblastic lymphomas expressing the non-disulfide-linked form of the T-cell receptor γ/δ: characterization with monoclonal antibodies and genotypic analysis Blood 1989 74: 2501–2507
Jaffe ES, Krenacs L, Kumar S, Kingma DW, Raffeld M . Extranodal T cell and NK cell neoplasms Am J Clin Pathol 1999 111: (Suppl.1) 46–55
Kinney MC . The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T-cell or NK-cell neoplasms Am J Clin Pathol 1999 111: (Suppl.1) 104–118
Hui PK, Feller AC, Pileri S, Gobbi M, Lennert K . New aggressive variant of suppressor/cytotoxic T-CLL Am J Clin Pathol 1987 87: 55–59
Hansen CA, Bockenstedt PL, Schnitzer B, Fox DA, Kueck B, Braun DK . S100-positive, T-cell chronic lymphoproliferative disease: an aggressive disorder of an uncommon T-cell subset Blood 1991 78: 1803–1813
Ascani S, Leoni P, Fraternali Orcioni G, Bearzi I, Piccioli M, Materazzi M, Zinzani PL, Gherlinzoni F, Falini B, Pileri SA . T-cell prolymphocytic leukemia: does the expression of CD8+ phenotype justify the identification of a new subtype Ann Oncol 1999 10: 649–653
Acknowledgements
Figure 1 was kindly provided by Prof ML Hansmann, Department of Pathology, JW Goethe University, Frankfurt am Main, Germany
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weidmann, E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 14, 991–997 (2000). https://doi.org/10.1038/sj.leu.2401784
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401784
Keywords
This article is cited by
-
Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma
Annals of Hematology (2023)
-
Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma
Journal of Cancer Research and Clinical Oncology (2021)
-
CD56 Negative Aggressive T Cell Large Granular Lymphocytic Leukemia
Indian Journal of Hematology and Blood Transfusion (2016)